A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis

Alvaro, J. et al. (2005) A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis. Annals of the Rheumatic Diseases, 64, pp. 64-69. (doi:10.1136/ard.2003.020347) (PMID:15242865) (PMCID:PMC1755211)

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:McInnes, Professor Iain
Authors: Alvaro, J., Furst, D., Genovese, M., Herrero-Beaumont, G., Kivitz, A., McInnes, I., Musikic, P., Nuki, G., Pavelka, K., Rozman, B., Stahl, H., Tak, P., van, H., and Vencovsky, J.
College/School:College of Medical Veterinary and Life Sciences
College of Medical Veterinary and Life Sciences > Institute of Infection Immunity and Inflammation
Journal Name:Annals of the Rheumatic Diseases
Publisher:B M J Group
ISSN:0003-4967
ISSN (Online):1468-2060

University Staff: Request a correction | Enlighten Editors: Update this record